Our study showed that measurement of preoperative VEGF serum levels in patients with nonmetastatic CCRCC may be more useful than using IHC to assess VEGF expression in tumor tissues for prediction of postoperative recurrence after nephrectomy. The gene discussed is VEGFA; the disease is nonpapillary renal cell carcinoma.